| 000 | 00869 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518005438.0 | ||
| 264 | 0 | _c20190710 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2018-09-875203 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaddocks, Kami | |
| 245 | 0 | 0 |
_aChemotherapy-free induction in MCL: ready for prime time? _h[electronic resource] |
| 260 |
_bBlood _c11 2018 |
||
| 300 |
_a2001-2002 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 | _aLymphoma, Mantle-Cell |
| 650 | 0 | 4 | _aRituximab |
| 773 | 0 |
_tBlood _gvol. 132 _gno. 19 _gp. 2001-2002 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2018-09-875203 _zAvailable from publisher's website |
| 999 |
_c29025724 _d29025724 |
||